Stem cell discovery furthers research on cell-based therapy and cancer

July 19, 2013

Stem-cell researchers at UC San Francisco have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace damaged organs in the human body.

"Scientists have known that Bmi1 is a central control switch within the adult of many tissues, including the brain, blood, lung and mammary gland," said Ophir Klein, MD, PhD, who directs the Craniofacial and Mesenchymal Biology (CMB) Program and serves as chair of the Division of Craniofacial Anomalies at UCSF. "Bmi1 also is a cancer-causing gene that becomes reactivated in ."

Klein's research group now has shown that BMI1 plays another role in ensuring that the process of development unfolds normally.

The hallmarks of all stem cells are that they are immature, they keep dividing to replenish their numbers almost indefinitely, and they generate new specialized cells to function in the tissues in which they reside, a process called .

Pushed in one direction, the BMI1 switch enables normal stem cells to divide and renew their own numbers. Thrown in the other direction, it keeps in check. But now, Klein's research team has shown that BMI1 also keeps this stock of stem cells from spinning off that mature into the wrong type of specialized cell in the wrong place.

The new discovery suggests that manipulating BMI1, along with other regulatory molecules, might one day be among the steps included in molecular recipes to turn specialized cell development on and off to create new cell-based treatments for tissues lost to injury, disease or aging, Klein said.

The dual role of BMI1 also is intriguing to think about in pathological settings, such as cancer, Klein said. Growing evidence suggests that many cancers are driven by abnormally behaving adult stem cells or by cells that have abnormally acquired stem-cell-like properties. If these could be made to become specialized cells rather than stem cells when they divide, it might slow tumor growth, some cancer researchers believe. Inactivating BMI1 in cancer stem cells might be one strategy, Klein suggested.

The study by Klein's research team is published in the July issue of Nature Cell Biology, and was conducted on adult stem cells found in the large incisors of mice.

Klein, a faculty member of the UCSF School of Dentistry, as well as the School of Medicine, studies teeth, intestines and other tissues to understand the biology and molecular mechanisms that regulate stem cells in these organs. Knowledge gained in these studies can further fuel his specific interest in finding new ways to generate replacement tissue to treat conditions such as Crohn's disease and craniofacial abnormalities—and to grow new teeth.

The incisor of the mouse, unlike any human tooth, grows continuously, and is an attractive focus for stem cell research, in Klein's view. "There is a large population of stem cells, and the way the daughter cells of the stem cells are produced is easy to track—it's as if they are on a conveyor belt," he said. Early in life humans possess stem cells that similarly drive tooth development, but they become inactive after our adult teeth are fully formed during early childhood.

In the current study, postdoctoral fellows Brian Biehs, PhD, and Jimmy Hu, PhD, determined that there is a group of at the base of the growing mouse incisor and that these stem cells possess active BMI1. They showed that BMI1 can suppress a set of genes called Hox genes that, when activated, trigger the development of specific cell types and body structures. In the mouse incisor, the researchers showed that activity of BMI1 in the stem cells maintains their stem cell fate and prevents inappropriate cell differentiation by suppressing the expression of Hox genes.

This essential developmental role of BMI1 in watchdogging the production of specialized cells is likely to have been conserved through evolution, because studies of Hox genes in fruit flies suggests that there may be a similar role for BMI1 in insects as well as mammals, Klein said.

Using the mouse incisor, Klein and his colleagues intend to continue exploring how stem cells and their behaviors are molded in turn by cues they receive from surrounding cells.

"This new knowledge is useful in a fundamental way for understanding how cell differentiation is controlled, and may help us manipulate stem cells to get them to do what we want them to do," Klein said.

Explore further: Cancer hijack

More information: www.nature.com/ncb/journal/v15/n7/abs/ncb2766.html

Related Stories

Cancer hijack

July 19, 2013
Genetically unstable breast cancer cells appear to hijack a mechanism used by healthy stem cells to determine how they should develop into different tissues, according to new research.

'Imprinted' developmental genes gain new roles in adult stem cells

September 8, 2011
(PhysOrg.com) -- The repair of tissues damaged by injury or illness relies on the ability of adult stem cells to grow and self-renew. But this ability needs to be tightly controlled; if regulation is lost, the stem cells ...

Study shows how the Nanog protein promotes growth of head and neck cancer

June 18, 2013
A study led by researchers at The Ohio State University Comprehensive Cancer Center-– Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) has identified a biochemical pathway in cancer ...

Stem cell treatment to prevent leukemia returning is a step closer, say scientists

June 2, 2011
Researchers at King's College London have identified a way of eliminating leukaemic stem cells, which could lead to new treatments that may enable complete remission for leukaemia patients. An early study in mice has shown ...

Stem cell odyssey leads from tusks and teeth to gut

January 11, 2012
Look at the teeth on the lab specimen here. Is this the work of a mad scientist?

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.